We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDW.WS.A
6851
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
$0 ﹤0.01%
28
TDW.WS.B
6852
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$0 ﹤0.01%
30
VRAY
6853
PUT
DELISTED
ViewRay, Inc.
VRAY
-1,100,000
Closed -$3.19M
NMTR
6854
DELISTED
9 Meters Biopharma
NMTR
0
NOVN
6855
DELISTED
Novan, Inc. Common Stock
NOVN
-25
Closed -$1K
ISEE
6856
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$0 ﹤0.01%
+1
New +$4
HEXO
6857
DELISTED
HEXO Corp. Common Shares
HEXO
-14,488
Closed -$3.21M
STCN
6858
DELISTED
Steel Connect, Inc. Common Stock
STCN
$0 ﹤0.01%
+15
New +$209
HVBC
6859
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
-25
Closed
UNAM
6860
DELISTED
Unico American Corp
UNAM
$0 ﹤0.01%
9
-55
-86% -$356
OIL
6861
DELISTED
iPath Pure Beta Crude Oil ETN
OIL
-7,900
Closed -$130K
SNMP
6862
DELISTED
Evolve Transition Infrastructure LP
SNMP
-148
Closed -$2K
BLCM
6863
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
7
-9
-56% -$83
SEAC
6864
DELISTED
Seachange International Inc
SEAC
-26
Closed -$2K
BIOC
6865
DELISTED
Biocept, Inc.
BIOC
0
VYNT
6866
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
-3
Closed
BSMX
6867
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
-156,972
Closed -$989K
LMST
6868
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
-25
Closed
PRVB
6869
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$0 ﹤0.01%
1
-3,769
-100% -$33.6K
IBA
6870
DELISTED
Industrias Bachoco SAB De C.V.
IBA
-54
Closed -$3K
PLXP
6871
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-66
Closed
APEN
6872
DELISTED
Apollo Endosurgery, Inc.
APEN
-146
Closed
AGFS
6873
DELISTED
AgroFresh Solutions Inc
AGFS
$0 ﹤0.01%
+8
New +$19
ASPU
6874
DELISTED
ASPEN GROUP, INC.
ASPU
-75
Closed
TMDI
6875
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
-20,987
Closed -$23K

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.